Figure 1.
Progression-free survival. Progression-free survival defined as time from the end of first-line therapy to disease progression or death for patients in CR or PR after treatment with 2-CdA, CC, or CMC.
Progression-free survival. Progression-free survival defined as time from the end of first-line therapy to disease progression or death for patients in CR or PR after treatment with 2-CdA, CC, or CMC.
